Palleon Pharmaceuticals
Rakesh Dixit has over 30 years of experience as a successful executive, scientist, and inventor in the biopharmaceutical industry. Prior to becoming a full-time consultant, Rakesh was Executive Vice President of R&D and Global Head of Biologics Safety Assessment for MedImmune/AstraZeneca. He also served as a Director of Research for Merck and Johnson & Johnson. During the course of his career, Rakesh contributed to the successful approval of 10 biopharmaceutical products. He has a Ph.D. from the University of Lucknow in India, and he continued his studies at Case Western Reserve University School of Medicine.
This person is not in the org chart
This person is not in any offices
Palleon Pharmaceuticals
Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer.